Opus Point Partners Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $259K | Hold |
4,082
| – | – | 0.47% | 47 |
|
|
2019
Q2 | $276K | Buy |
4,082
+415
| +11% | +$28.1K | 0.41% | 54 |
|
|
2019
Q1 | $238K | Sell |
3,667
-951
| -21% | -$61.7K | 0.32% | 69 |
|
|
2018
Q4 | $289K | Buy |
4,618
+85
| +2% | +$5.32K | 0.64% | 28 |
|
|
2018
Q3 | $350K | Buy |
4,533
+282
| +7% | +$21.8K | 0.84% | 41 |
|
|
2018
Q2 | $301K | Buy |
4,251
+584
| +16% | +$41.4K | 0.65% | 35 |
|
|
2018
Q1 | $276K | Buy |
3,667
+592
| +19% | +$44.6K | 0.54% | 42 |
|
|
2017
Q4 | $220K | Sell |
3,075
-3,387
| -52% | -$242K | 0.19% | 53 |
|
|
2017
Q3 | $524K | Buy |
6,462
+3,206
| +98% | +$260K | 0.47% | 43 |
|
|
2017
Q2 | $230K | Sell |
3,256
-2,481
| -43% | -$175K | 0.21% | 52 |
|
|
2017
Q1 | $390K | Buy |
5,737
+2,329
| +68% | +$158K | 0.29% | 50 |
|
|
2016
Q4 | $244K | Buy |
+3,408
| New | +$244K | 0.19% | 46 |
|
|
2016
Q2 | – | Sell |
-3,282
| Closed | -$301K | – | 47 |
|
|
2016
Q1 | $301K | Sell |
3,282
-30,418
| -90% | -$2.79M | 0.23% | 51 |
|
|
2015
Q4 | $3.41M | Buy |
33,700
+29,377
| +680% | +$2.97M | 2.25% | 19 |
|
|
2015
Q3 | $424K | Buy |
4,323
+89
| +2% | +$8.73K | 0.23% | 41 |
|
|
2015
Q2 | $496K | Buy |
4,234
+583
| +16% | +$68.3K | 0.39% | 48 |
|
|
2015
Q1 | $358K | Sell |
3,651
-677
| -16% | -$66.4K | 0.3% | 61 |
|
|
2014
Q4 | $408K | Buy |
+4,328
| New | +$408K | 0.4% | 49 |
|